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Cell fate and cell death are central to any 
multicellular organism’s normal development. Our 
lab pioneered the use of the nematode 
Caenorhabditis elegans in studying the 
fundamental processes that control cell fate and 
death, two events that cannot be divorced from one 
another. We discovered several cell lineage 
mutants, including lin-4, let-7, lin-12 and lin-14, 
which affect developmental timing and control. The 
effects of some of these mutations on the 
development of the vulva are examined here, which 
includes programmed cell death (PCD). The 
molecular genetic pathway of PCD was determined 
over the course of more than 20 years of study. The 
following mutations are known to act in PCD; ces-2, 
ces-1, tra-1, egl-1, ced-9, ced-3, ced-4, ced-11, ced-
1, ced-6, ced-7, ced-2, ced-5, ced-10, ced-12 and 
nuc-1. The discovery of human homologues of 
most of these genes has shown that the PCD 
pathways in worms and humans are evolutionarily 
conserved. This conservation has proved to have 
immense implications on research for cures of 
many human disorders like neurodegenerative 
diseases and cancer, which are hypothesized to be 
caused by malfunctions in the PCD pathway. C. 
elegans has proved to be a truly noble organism, 
providing targets in the PCD pathway for 





I was delighted to be accepted as a researcher in 
Sydney Brenner’s laboratory at the Medical Research 
Council Laboratory of Molecular Biology in England, in 
1974. Sidney Brenner had established C. elegans as a 
model system to study genetics.
1
 There, I started my 
studies of C. elegans with John Sulston, who was 
trained as an organic chemist. John used his chemical 
expertise to study the neurochemistry of the nematode. 
He was studying the larval ventral nervous system, by 
using Nomarski differential interference contrast optics 
to visualize individual cells within the animal.
2
 By 
looking at single cells, he could follow each cell division 
and the fates of the descendent cells. 
____________________________________________ 
 
*This author wrote the paper for Biology 346: Molecular Neuroscience, 
taught by Dr. Shubhik DebBurman. 
 We already knew that some cells died by 
“programmed cell death” (PCD) in the normal process  
of development.
3
 In my studies of the C. elegans cell 
lineage, we observed that many cells undergo PCD at 
different times during development. Since the C. 
elegans cell lineages are so rigid and invariant, we 
hypothesized that cell death was also a fate. Our 
hypothesis has been supported by the data from our lab 
and other laboratories who have been studying PCD. 
Most importantly, the conservation of genes in the PCD 
or apoptosis pathway between nematodes and humans 
has had implications on the search for cures of 
neurodegenerative diseases and cancers, thought to be 
caused by abnormalities in the PCD pathway.  
 C. elegans has been an ideal organism to 
study cell lineage and PCD. It has proved to be a truly 
noble organism which has revealed the genetic 
similarities that it shares with us. I hope that future 
studies in C. elegans will help unfold many more 
mechanisms and pathways that are common to both 
nematodes and humans. In this paper, I will describe 
our discovery of genes affecting cell lineage, the 
development of the vulva, and programmed cell death.  
   
Cell Lineage and Genetics 
 
I was very excited to be working with John. Together, 
we characterized the post-embryonic cell lineages of C. 
elegans.
4
 The lineages of the cells in the gonad were 
described two years later.
5
 But the embryonic cell 
lineages, which were much more difficult to 
characterize, was done later by John along with other 
colleagues.
6
 These studies defined the complete cell 
lineage of C. elegans. 
 Now that we knew the rigid and invariant cell 
lineages, we wanted to know the mechanisms 
underlying them. One method was to kill individual cells 
using a laser micro beam and thus study the effects of 
individual cells. The second was through genetics. 
Following up on our previous study, John and I isolated 
and characterized 24 mutants of the post-embryonic 
cell lineages of the nematode.
7, 8
 Many of the cell 
lineage mutants we isolated controlled developmental 
timing rather than being homeotic (mutations in these 
genes cause body parts usually found in one part of the 
body to be found elsewhere). We named these, 
heterochronic mutants. There are two types of 
heterochronic mutants; a mutation that can cause early 
developmental events to occur late, and mutations that 
cause late development events to occur early.
9
 Lin-4 
(lin, cell lineage abnormal) and unc-86 (unc, 
uncoordinated movement) were found to cause 
repetition of cell division patterns normally associated 
with their descendents.
10
  Similar genes have been 
identified in other metazoans and are necessary for the 
propagation of stem cells.
10
 We also identified let-7, 
which coded for a 21 nucleotide RNA required to 
control developmental timing in the adult larva.
11
 Loss 
of let-7 caused reiterations whereas increased let-7 






Figure 1. I. Each cell (A) has a fate, which could be to differentiate into a specific cell type or to undergo a specific differentiation pattern (B 
and C). In I, cell A gives rise to daughter cells B and C, which have different fates. In II, cell A, produces two cells B and B, which have the 
same fates. Similarly, in wildtype animals, the 2˚ blast cells divides to produce daughter cells with different fates, while in lin-12 mutants, all 




All cells can be thought of as having a certain fate. The 
fate could be to differentiate into specific cell types or to 
undergo a specific pattern of cell division.
9
 For 
example, cell A can divide to produce two cells B and 
C, where B and C are different from each other and 
from the mother cell A. We found that Unc-86 and lin-11 
control cell diversity.
12
 Mutating lin-11 caused daughter 
cells to be like each other instead of differentiating 
(Figure 1).
13
 We also found that unc-86 and lin-11 have 
counterparts in other organisms. In fact, they are both 




 In order to differentiate between cells that 
have direct as opposed to indirect effects, we named 
some genes “important developmental control genes” 
(IDCGs). Mutations in these genes have opposite 
developmental effects.
15
 Lin-12, an IDCG was first 
found to affect the development of the vulva.
16, 12
 We 
found that lin-12 acts at the time cell fate is determined, 
and an increase or decrease in lin-12 activity causes 
alternative fates.
16
 Victor Ambros, a post doctoral fellow 
in my laboratory isolated and characterized lin-14, 
another heterochronic mutant which was also an 
IDGC.
17
 Increasing lin-14 activity lead to retarded 
development, whereas reducing lin-14 activity caused 
precocious development.
17
 Lin-14 also controls cell 
fates in a number of cell lineages including the 
hypodermis, mesoderm and intestines.
17
 We later found 
that a reduction in lin-14 protein levels during 
development causes the expression of different cell 




Development of the Vulva 
The vulva is the opening of the uterus to the 
environment. It is used for egg laying and mating. In the 
course of our cell lineage studies, we have studied the 
genetic pathway necessary for the development of the 
vulva which involves 3 rounds of cell division. In C. 
elegans, mutations in the vulva are easily identifiable 
and thus easier to study.
12
 Vulval mutations can result 
in an animal with no vulva, termed “vulvaless.” Since 
the vulva is required for egg-laying, in vulvaless 
hermaphrodites, the eggs are self-fertilized and hatch in 
utero, causing the death of the parent, but not the 
progeny. Mutations can also result in a “multivulva” 
phenotype, where the animal has multiple ectopic 
vulvae. 
 We found that in some vulvaless mutants (lin-
2, lin-3, and lin-7), the first round of cell divisions are 
normal, however, the second round of cell divisions 
generally fail.
8
 In the hermaphrodite multivulva mutants, 
(lin-1 and the double mutant lin-8; lin-9), all cells that 
undergo the first round of cell divisions (P3.p-P8.p), 
also undergo the second round of cell divisions.
8
 The 
additional vulvae are caused due to further cell 
divisions in P3.p-P6.p in the lin-8; lin-9 mutants.
8
 
 In a study, we found that, of the 23 genes 




 15 of these genes are involved in 
intracellular signaling to the extracellular signal that 
induces vulval development.
19
 Later studies showed 
that the fate of each vulval precursor cell (VPC) 
depended on two signaling pathways, one graded 
inductive signal functioning from a distance and a short 
range lateral signal between the VPCs. We showed that 
lin-12 acts in the lateral signaling pathway and specifies 
2˚, one of the three VPC cell fates. The vulvaless and 
multivulva genes act in the inductive signaling pathway 




 The genetic studies from my laboratory, 
along with other studies, have helped in elucidating the 
Ras pathway for signal transduction. We found that let-
60 is an essential ras gene and it acts as a switch in the 
inductive signal pathway for vulval development.
21
 
Thus, recessive mutations that reduce let-60 lead to a 
vulvaless mutant phenotype (3˚ fate), whereas 
dominant mutations that increase let-60 activity lead to 
development of the vulva, even in the absence of the 
inductive signal (1˚ and 2˚ fate).
 21
 Our studies of the 
Ras pathway have showed that this pathway is 
conserved in worms and mammals. We found that two 
genes lin-35 and lin-53, code for proteins very similar to 
the tumor suppressor protein Rb and its binding protein 
RbAp48, respectively.
22
 These proteins act as 
transcription factors that antagonize the Ras pathway 
thereby inhibiting vulval formation. Recently, we 
discovered that lin-8 codes for nuclear protein LIN-8, 
which interacts with LIN-35 Rb. Thus, we have shown 
compelling evidence that vulval induction is controlled 
by transcriptional regulation of gene expression. 
 
Programmed Cell Death (PCD) 
 
Naturally occurring cell death or “programmed” cell 
death occurs in vertebrates 
24
 and invertebrates 
25
 
during normal animal development. It is a fundamental 
part of development which was observed, but not very 
well studied. During my studies of the C. elegans cell 
lineage I was intrigued by the phenomena of 
programmed cell death. Of the 959 cells generated 
during the normal development of the hermaphrodite 
worm, an additional 131 cells are generated which 
undergo programmed cell death.
4
 Interestingly, 105 of 




 From our cell lineage studies, we knew that 
diverse cells in different developmental stages undergo 
programmed cell death, giving rise to the invariant cell 
lineages of C. elegans. In cells undergoing PCD, the 
morphological changes occurring were all very similar. 
This made identification of these cells by direct 
screening fairly simple. The first sign of a cell 
undergoing cell death is that there is a slight increase in 
its refractility. Next, the nucleus of the dying cell 
becomes very refractile and looks like a flat button; this 
lasts for about 10-30 minutes. In the last stage, the 
dying cell is engulfed and the nucleus decreases in 
refractility, becomes crumpled and finally disappears.
26
 
We reasoned that since PCD is a series of 
morphological changes, then it could be treated as a 
cell fate. We decided to use genetic methods to identify 
genes that induce the cell to die and genes that carry 
out the execution. 
Identification of Genes in the Cell Death Pathway 
The first gene in the PCD pathway was nuc-1 (nuclease 
abnormal). This gene was identified by John Sulston in 
his studies of the cell lineages of the ventral nervous 
system. He used Feulgen DNA staining to observe 
these cells. In the nuc-1 mutants, the DNA of dead cells 
was still visible and did not perish. John showed that 
these mutants lacked endonuclease activity required to 





In 1983, Ed Hedgecock et al. discovered two more cell 
death genes, ced-1 and ced-2 (cell death abnormal). In 
these mutants, phagocytosis or the normal process of 
cell engulfment does not occur, making the cell corpses 
persist in the animal. These corpses can be visualized, 
since dead cells become refractile. Hedgecock et al. 
also saw that in ced-1 and ced-2 mutants, the DNA of 
dead cells persist. By creating a double mutant with 
ced-1/ced-2 and nuc-1 knocked out, they showed that 
ced-1 and ced-2 are required for nuc-1 activation, and 
thus placed ced-1 and ced-2 upstream of nuc-1.
27
 This 
also suggested that nuc-1 was probably expressed by 
the engulfing cell. 
 In later studies, my laboratory discovered five 
new genes that played a role in cell engulfment. We 
named these ced-5, ced-6, ced-7, ced-8 and ced-10.
28
 
We observed that mutations in each of these genes 
prevented cell engulfment, thus these genes must be 
involved in cell recognition or initiation of phagocytosis. 
We made double mutants which suggested that these 
genes act in distinct and partially redundant pathways. 
In double mutants of ced-2, ced-5 and ced-10, the 
same number of cells were unengulfed as in ced-5 
single mutants alone. However in double mutants 
between ced-2, ced-5 or ced-10, and ced-1, ced-6, ced-
7 or ced-8, there were more unengulfed cells.
28
 These 
results suggested that ced-2, ced-5 and ced-10 act in 
one cell engulfment pathway while ced-1, ced-6 and 
ced-7 act in a second pathway.
28
 We also found that 
ced-12 is part of the ced-2, ced-5 and ced-10 pathway. 
 Later, we found that CED-1, CED-6 and 
CED-7 proteins are part of a signaling pathway that is 
essential for cell corpse recognition. We also found that 
CED-1 is a transmembrane receptor, similar to the 
human scavenger receptor SREC, which clusters 
around dead cells.
29
 CED-6 acts downstream of CED-1 
and is similar to mammalian adaptor proteins that 
contain phosphotyrosine binding (PTB) domains
29
, 
while CED-7 is similar to the ATP binding cassette 
transporters
30
 and promotes cell corpse recognition by 




 We also found that CED-2, CED-5 and CED-
10 proteins are components of a conserved Rac 
GTPase signaling pathway. The Rho/Rac pathway is 
involved in dynamic processes such as cell motility, 
phagocytosis, axonal guidance and cytokinesis.
31
 CED-
2 is similar to the mammalian adaptor protein CrkII, 
which is implicated in transmembrane-receptor 
mediated signaling pathways.
32
 CED-5 was found to be 
similar to human DOCK180, a Crk-interacting protein 
33
, 
while CED-10 is a C. elegans homolog of mammalian 
Rac. Ced-12 encodes a protein which is also part of the 
CED-10 Rac pathway.
34
 We also found that defects in 
 82 
CED-2, CED-5 and CED-12 not only affect cell 
engulfment, but also cell migration.
32
   
 
Ced-3 
In order to identify genes abnormal in the PCD 
pathway, we decided to use the ced-1 and ced-2 
mutants, since apoptotic cells, despite being visible, are 
engulfed and degraded quite rapidly. In ced-1 and ced-
2 animals, cells that normally undergo PCD die, but are 
not engulfed and persist for a few hours. Hilary Ellis, a 
graduate student in my laboratory, mutagenized the 
ced-1 strain and found a mutant where no cell corpses 
could be seen. We named this gene ced-3. We showed 




 We had showed that ced-3 is required for 
PCD to occur. This meant that PCD was among 
fundamental biological processes encoded for by 
genes, like cell division, cell differentiation, etc. Next, 
we came up with a genetic pathway for cell death 
where ced-3 acts upstream of ced-2 and ced-1 which 
act upstream of nuc-1. 
 In 1993, we found that ced-3 encodes a 
protein similar in sequence to the mammalian 
interleukin-1 beta-converting enzyme (ICE).
36
 ICE 
cleaves the pro form of the cytokine interleukin-1-beta, 
thereby converting it into the active form.
37
 Later we 
showed evidence that CED-3 is a cysteine protease 
which cleaved substrates similar to the mammalian 
CPP32 protease, rather than to ICE.
38
 We also showed 
that CED-3 protease activity is required for PCD to 
occur.
38
 There has also been extensive evidence from 
other laboratories that caspases play an important role 
in PCD.
39, 40
 Together these studies provided evidence 
that the cell death pathway is conserved between 
nematodes and humans. 
 
Ced-4 
In the course of our cell lineage studies, we discovered 
and characterized 145 mutants that are defective in egg 
laying.
41
 One of these mutants lacked the 
hermaphrodite specific motor neurons (HSNs) required 
for egg laying. We named this gene egl-1 (egg-laying 
abnormal). We thought that since the HSN motor 
neurons were missing, they probably died by PCD, 
because of the egl-1 gain of function (gf) mutation, that 
is, a mutation that abnormally activates egl-1. We 
created a double mutant egl-1; ced-3 and compared it 
to egl-1 and saw that mutating ced-3 leads to the 
survival of the HSNs showing that these cells die by 
PCD.
26
 We looked for other mutations that block the 
egl-1 phenotype and discovered ced-4, which acts very 
similar to ced-3. We now know that egl-1 acts upstream 
of ced-3 and ced-4, since an egl-1(gf) mutation leads to 
PCD, while blocking ced-3 or ced-4 does not. 
 Next, we wanted to know if ced-3 and ced-4 
act within the dying cells or are activated in some 
neighboring cells. We used genetic mosaic analyses, 
where a single animal has some cells that are mutant 
(ced-3/ced-4) and some that are not, to answer our 
question. We discovered that ced-3 and ced-4 act cell 
autonomously, i.e. they act within the dying cells.
42
 This 
implied that these cells committed suicide. 
 We did not know if ced-3 and ced-4 acted 
together, or if one gene was upstream of the other. 
Overexpression of ced-4 using a transgene in ced-3 
mutants did not increase the number of cells dying by 
PCD, showing that ced-3 activity was required.
43
 Also, 
overexpression of ced-3 in ced-4 mutants did not 
require ced-4 function, providing further evidence that 
ced-4 acts upstream of ced-3 
43
. 
 Our laboratory found that ced-4 encodes a 
novel protein that is highly expressed during 
programmed cell death.
44
 It was later found that CED-4 
was similar to apaf-1 (apoptotic protease activating 
factor), a human protein that is highly expressed during 
PCD (apoptosis).
45
 This was very significant as like 
CED-3, it showed that the PCD pathway is conserved 
between nematodes and humans. 
 
The ced-9 Gene Prevents Programmed Cell Death 
In 1992, a study from our laboratory showed that the 
activity of the ced-9 gene protects cells against PCD.
46
 
We showed that a ced-9 (gf) mutation prevents the cell 
deaths that occur during normal C. elegans 
development.
46
 Mutations in ced-9 (gf) and ced-3 and 
ced-4 all prevented PCD and about the same number 
of extra cells were found in all three mutants.
46 
We also 
found that a ced-9 (lf) mutation, i.e. a mutation that 
inactivates ced-9 causes the death of embryos 
46
. In 
order to place ced-9 in our developing PCD pathway, 
we created double mutants using ced-9 (lf), and ced-3 
or ced-4. Mutations in either ced-3 or ced-4 completely 
suppressed PCD in ced-9 (lf) animals. This meant that 
ced-9 was upstream of ced-3 and ced-4 as these genes 




 We asked if ced-9 protects against PCD, by 
inhibiting ced-3, ced-4 or both, and found out that 
protection conferred by ced-9 against ced-3 killing, is 
reduced when ced-4 is mutated.
43
 We also saw that 
overexpressing ced-9 can protect against ced-4 
overexpression.
43
 Our results suggested that ced-9 
inhibits ced-3, at least partly by inhibiting ced-4.  
 Our laboratory discovered that ced-9 
encodes a protein which shows 23% identity to the 
product of the human proto-oncogene Bcl-2.
37
 We also 
showed that expressing human Bcl-2, can substitute for 
ced-9 in ced-9 mutants by protecting against PCD.
37
 
This discovery generated great interest in the worm 
cell-death pathway. Moreover, C. elegans proved to be 
an ideal model system for the study of the PCD 
pathway as so many genes were found to be conserved 
between nematodes and humans.  
 Our next question was what controls ced-9 
activity? We had already isolated the egl-1 (gf) mutant 
which caused the hermaphrodite specific neurons to 
undergo PCD. We found that in egl-1 (lf) mutations, not 
only do the HSNs survive, but cells in the anterior 
pharynx also survive.
47
 Thus, egl-1, like ced-9 (gf), ced-
3(lf) and ced-4 (lf), blocks all general programmed cell 
deaths.
47
 We cloned egl-1 and found that the EGL-1 
protein contains a 9 amino acid region which is similar 
to the BH3 domain of the Bcl-2 like and BH3 containing 
proteins.47 Using an in vitro binding assay we found 
that EGL-1 and CED-9 proteins interact physically. 
These results suggested that EGL-1 may be a member 
of the cell death activator proteins. 
  
Other Genes in the Programmed Cell Death Pathway 
In our studies of the cell death pathway we discovered 




Figure 2. The Molecular Genetic Pathway of Programmed Cell Death (PCD) in C. elegans. 
Ces-2 and ces-1 are required by specific cells to decide to die. Ces-1 and/or tra-1 inhibit egl-1, which negatively controls the activity of ced-
9, an inhibitor of PCD, by controlling ced-3 and ced-4. Ced-3 is activated by ced-4S and ced-3 activates ced-11. Two parallel and partially 
redundant pathways regulate cell engulfment. These are the ced-1, ced-6, ced-7 pathway and the ced-2, ced-5, ced-10 and ced-12 




named these genes ces-1 and ces-2 (ces, cell death 
specification).48 We discovered that a gain of function 
mutation in ces-1 prevented the deaths of the sisters of 
the serotonergic neurosecretory motor (NSM) neurons, 
and the sisters of the I2 neurons which die in normal 
development, whereas a loss of function mutation in 
ces-1 caused the NSM sisters to die. A reduction of 
ces-2 activity also lead to the survival of the NSM 
sisters, showing that ces-2 was needed to cause 
PCD.48  
 We created double mutants of animals with 
ces-1 (lf) and a mutation in either ced-3 or ced-4. We 
found that the NSM sisters lived just as they did in the 
ced-3 and ced-4 mutations.  This indicated that ces-1 
was upstream of ced-3 and ced-4. We also found that 
in a ces-1 ces-2 double mutant, the NSM sisters died, 
just as they do in loss of ces-1 (lf) mutants or in ces-2 
mutants.48 These results along with genetic studies 
helped us place these two genes in the genetic 
pathway of PCD (Figure 2). 
 Our lab discovered that both ces-1 and ces-2 
encode transcription factors with human homologues. 
Ces-1 encodes a transcription factor of the zinc finger 
family, whose human counterpart is SLUG, 49 while 
ces-2 encodes a transcription factor which is similar to 
the product of the human proto-oncogene HLF (hepatic 
leukemia factor ).9 Both HLF and SLUG have been 
shown to regulate PCD in mammalian cells and may 
play a role in cancer by affecting PCD. 
 Tra-1 is another gene which regulates the 
deaths of specific cells. It regulates the sexually 
dimorphic programmed cell deaths of the HSN neurons 
(which die in males and survive in females).50 TRA-1A, 
coded for by tra-1, is also a zinc finger protein which 
acts as a transcription factor. In hermaphrodites, which 
have high TRA-1 activity, it binds to egl-1 and 
represses it. Repressing egl-1 allows ced-9 to block 
ced-4 and ced-3, preventing PCD (Figure 2). In egl-1 
(gf) mutations, the binding site of TRA-1 is disrupted, 
causing egl-1 to be highly expressed and leading to the 




Our studies of cell lineage and programmed cell death 
have enabled us to discover the basic pathway for cell 
death in C. elegans (Figure 2). However, in spite of 
knowing so much about the PCD pathway in C. 
elegans, there are still many unanswered questions. 
For instance, what makes the 131 cells in the 
developing hermaphrodite decide to die? What are the 
specific substrates of the caspases? What are the other 
genes in the PCD pathway? Current research in our lab 
is trying to answer these questions.  
 The discovery of human homologues of most 
of the genes in the PCD pathway has shown that the 
PCD pathways in worms and humans are evolutionarily 
conserved. This conservation has proved to have 
immense implications on research for cures of many 
human disorders like neurodegenerative diseases and 
cancer, which are hypothesized to be caused by 
malfunctions in the PCD pathway. Too much PCD is 
thought to cause Alzheimer’s disease, Parkinson’s 
disease and Huntington’s disease while too little PCD 
may be involved in cancer. By elucidating targets for 
possible neurodegenerative disease therapies, C. 
elegans has proven to be a useful model organism in 
the study of the PCD pathway. 
 84 
 C. elegans has yet again been shown to be a 
superb model organism for genetic studies to reveal 
pathways and mechanisms that are conserved in many 
organisms. The recent RNA interference studies in C. 
elegans have shed considerable light on the regulation 
of gene expression in humans, animals and plants. This 
important discovery in C. elegans was recognized by 
the Nobel Assembly, which awarded the Nobel Prize in 
physiology or medicine for 2006, jointly to Dr. Andrew 
Z. Fire and Dr. Craig C. Mellow. This is the second 
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